Showing results (31-40 of 114) with videos related to
Sort By:
Pageof 12
Clinical Genitourinary Cancer|May 27, 2017
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])Roberto Pili, Opeyemi Jegede, Michael A Carducci, et al.Cancer Chemotherapy and Pharmacology|March 26, 2005
A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109Peter J Van Veldhuizen, James R Faulkner, Primo N Lara, et al.JAMA Oncology|January 27, 2017
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical TrialGabriel N Hortobagyi, Catherine Van Poznak, W Graydon Harker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant TrialEdith A Perez, Vera J Suman, Nancy E Davidson, et al.Cancer|May 2, 2015
5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trialNina D Wagner-Johnston, Jeff A Sloan, Heshan Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemiaDavid P Steensma, Jeff A Sloan, Shaker R Dakhil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501William S Velasquez, Danika Lew, Thomas M Grogan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897Patricia A Ganz, Michael A Hussey, Carol M Moinpour, et al.Investigational New Drugs|May 16, 2006
A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group studyRobert P Whitehead, Sheryl McCoy, Saul E Rivkin, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2010
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)Aminah Jatoi, Shaker R Dakhil, Jeff A Sloan, et al.Pageof 12